Last reviewed · How we verify
NCT07420933
Pea vs Whey Protein Supplementation With Resistance Training on Young Adults' Strength, Body Composition, and Metabolic Parameters
NA trial testing Protein Isolate in Healthy Subjects in 34 participants. Completed in 6 December 2025.
6 December 2025
Quick facts
| Lead sponsor | Texas Woman's University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 34 |
| Start date | 3 February 2024 |
| Primary completion | 6 December 2025 |
| Estimated completion | 6 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Protein Isolate
- Progressive Resistance Exercise Training (PRE)
Conditions studied
- Healthy Subjects — all drugs for Healthy Subjects →
Sponsor
Texas Woman's University
Who can join
Adults 18 to 30, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the impact of pea protein or whey protein supplementation during a progressive resistance exercise (PRE) regimen on body composition and strength in young adults who are not undergoing regular strength training. The main questions it aims to answer are: 1. Do lean body mass changes differ between supplement groups following a progressive resistance exercise PRE training program? 2. Does improvements in muscle strength differ between groups following a PRE training program? 3. Does glucose, insulin, and essential amino acid appearance and clearance rate differ between groups following a PRE training program? Researchers will compare pea protein supplementation to whey protein supplementation to see if there are any differences in body composition and strength Participants will: * Consume Pea or Whey protein supplement twice daily for 8 weeks * Participate in a PRE training program twice weekly for approximately 1.5 hours per day
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07420933
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Subjects
Currently open trials in the same condition.
- NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
- NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
- NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting
Other Texas Woman's University trials
Trials by the same sponsor.
- NCT05074849 — Benefits of Insoles With Real-Time Alert and Foot Self-Care Education · NA · not yet recruiting
- NCT07493954 — Eat Healthy Grow Healthy Program to Promote Fruit and Vegetable Intake in Preschoolers · NA · active not recruiting
- NCT07020897 — Short-term and Intermediate-term Effects of Self-applied Joint Mobilization Versus Clinician-applied Joint Mobilization · NA · not yet recruiting
- NCT07130539 — Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hyperten · NA · active not recruiting
- NCT06705634 — How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07420933 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Woman's University
- Last refreshed: 19 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07420933.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing